A novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicated gastric cancer in treated mice, a multi-institutional team of researchers found.
To fight infections and heal injuries, immune cells need to enter tissue. They also need to invade tumors to fight them from within. Scientists from the Siekhaus group at the Institute of Science and Technology (IST) Austria ...
Immuno-oncology is a promising new field of research that involves boosting the capacity of a patient's own immune system to attack cancer cells. It has already proven to be effective in treating certain types of cancer, ...
A new technique could offer a targeted approach to fighting cancer: low-intensity pulses of ultrasound have been shown to selectively kill cancer cells while leaving normal cells unharmed.
Bioengineers and life scientists incorporate hybridoma technology to produce large numbers of identical antibodies, and develop new antibody therapeutics and diagnostics. Recent preclinical and clinical studies on the technology ...
There are thousands upon thousands of viruses in our various environments affecting our everyday life in a variety of ways. Many of those viruses infect humans by entering and exploiting the nasal route. Scientists at The ...
Every year, more than 18 million people around the world are told, "You have cancer." In the U.S., nearly half of all men and more than one-third of women will develop some kind of cancer during their lifetimes, and 600,000-plus ...
By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice.
Nanoscience research involves molecules that are only 1/100th the size of cancer cells and that have the potential to profoundly improve the quality of our health and our lives. Now nine prominent nanoscientists look ahead ...
Higher sales of vaccines and prescription medicines, coupled with restrained spending, helped Merck & Co. post a 20 percent jump in third-quarter profit, trouncing Wall Street expectations.
